| [1] |
Stacker SA, Williams SP, Karnezis T, et al.Lymphangiogenesis and lymphatic vessel remodelling in cancer[J].Nature Reviews Cancer, 2014, 14(3):159-172
|
| [2] |
鲁硕君, 秦艳茹, 常志伟.与胃癌非新辅助治疗患者预后关系的分析[J].河南医学研究, 2016, 25(05):783-786
|
| [3] |
尹中普, 杨琛.和-在喉癌组织中的表达及其与喉癌预后的关系[J].临床耳鼻咽喉头颈外科杂志, 2015, 29(13):1156-1159
|
| [4] |
Joukov V, Pajusola K, Kaipainen A, et al.A novel vascular endothelial growth factor,VEGF-C,is a ligand for the Flt-4(VEGFR-3),and KDR(VEGFR-2) receptor tyrosine kinasesEMBO J,1996; 15(2) :290-298[J].EMBO J, 1999, 15(2):290-298
|
| [5] |
Chen JC, Chang YW, Hong C, et al.The Role of the VEGF-CVEGFRs Axis in Tumor Progression and Therapy[J].Int J Mol Sci, 2013, 14(1):88-107
|
| [6] |
刘刚, 李金源.血管内皮生长因子与肿瘤生长的关系[J].军医进修学院学报, 2010, 31(01):93-94
|
| [7] |
尤晓光, 涂蓉.血管内皮细胞生长因子的家族成员及作用[J].海南医学院学报, 2008, (05):573-576
|
| [8] |
Cao Y, Linden P, Farnebo J, et al.Vascular endothelial growth factor C induces angiogenesis in vivo[J].Proceedings of the National Academy of Sciences of the United States of America., 1998, 95(24):14389-14394
|
| [9] |
Choi WW, ?Lewis MM, ?Lawson D, et al.Angiogenic and lymphangiogenic microvessel density in breast carcinoma:correlation with clinicopathologic parame-ters and VEGF-family gene expression[J].Mod Pathol, 2005, 18(01):143-152
|
| [10] |
Salven P, Mustjoki S, Alitalo R, et al.VEGFR-3 and CD133 identify a population of CD34+ lymphaticvascular endothelial precursor cells[J].Blood, 2003, 101(1):168-172
|
| [11] |
白英伟, 田兴松.骨髓间充质干细胞向淋巴管内皮细胞的分化潜能[J].中国现代普通外科进展, 2011, 14(05):344-349
|
| [12] |
Wei Zheng, ?Aleksanteri Aspelund, Kari Alitalo.Lymphangiogenic factors,mechanisms,and applications[J].J Clin Invest, 2014, 124(3):878-887
|
| [13] |
Hsu MC, Pan MR, Hung WC.Two Birds,One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3[J].Cells, 2019, 8(3):270-
|
| [14] |
Frias A, Lambies G, Vinas-Castells R, et al.A switch in Akt isoforms is required for Notch-induced Snail1 expression and protection from cell death[J].Mol Cell Biol, 2015, 36(6):923-940
|
| [15] |
Coon BG, Baeyens N, Han J, et al.Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex[J].J Cell Biol, 2015, 208(7):975-986
|
| [16] |
Dejana E, Vestweber D.The role of VE-cadherin in vascular morphogenesis and permeability control[J].Prog Mol Biol Transl Sci, 2013, 116:119-144
|
| [17] |
沈飞琼, 魏素菊.及其受体-与肺癌关系的研究进展[J].实用癌症杂志, 2013, 28(04):452-455
|
| [18] |
陶绍霖, 谭群友.信号通路在淋巴管生成及肺癌淋巴转移中作用机制的研究进展[J].中华临床医师杂志, 2011, 5(03):796-799
|
| [19] |
王静文, 唐建武.淋巴管内皮细胞受体研究新进展[J].临床与实验病理学杂志, 2017, 33(02):186-189
|
| [20] |
Ou J J, Wei X, Peng Y, et al.Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFCVEGFR3 independent signaling[J].Cancer Lett, 2015, 358(2):200-209
|
| [21] |
Xu Y, Yuan L, Mak J, et al.Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3[J].J Cell Biol, 2010, 188(1):115-130
|
| [22] |
Puig-Saus C, Rojas LA, Laborda E, et al.iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction,intratumoral dissemination and antitumor efficacy[J].Gene Ther, 2014, 21(8):767-
|
| [23] |
张莉芹, 田彩平, 马世红等.和-在组织中的表达[J].甘肃医药, 2014, 33(09):641-644
|
| [24] |
Manar AA, Amina KA, Dalia HE, et al.Lymphangiogenesis in oral squamous cell carcinoma: correlation with VEGF-C expression and lymph node metastasis[J].Int J Dent, 2017, :-
|
| [25] |
黄元清, 宋宇峰, 张建国.中-的表达及与颈淋巴转移的关系[J].临床口腔医学杂志, 2010, 26(03):145-147
|
| [26] |
陈思秀, 李小玉, 孔祥丽等.中血管内皮生长因子-的表达及其与血管、淋巴管生成、淋巴结转移的关系[J].华西口腔医学杂志, 2010, 28(03):319-323
|
| [27] |
冷其艳.VEGF-C及P27在OSCC中的表达及其意义分析[D].蚌埠医学院, 2012.
|
| [28] |
温玉明, 潘剑, 华成舸等.VEGF-C在舌鳞癌中的表达及其意义[J].中国口腔颌面外科杂志, 2003, (01):46-49
|
| [29] |
冯红超, 宋宇峰, 温玉明.口腔癌组织中血管内皮生长因子-C在肿瘤相关巨噬细胞内的表达及与淋巴结转移的关系[J].癌症, 2004, (03):278-281
|
| [30] |
Kudo Y, Ogawa I, Kitajima S, et al.Periostin promotes invasion and anchorage -independent growth in the metastatic process of head and neck cancer[J].Cancer Res, 2006, 66(14):6928-6935
|
| [31] |
Kudo Y, Kitajima S, Ogawa I, et al.Invasion and metastasis of oral cancer cells require methylation of E - cadherin andor degradation of membranous -catenin[J].Clin Cancer Res, 2004, 10(16):5455-5463
|
| [32] |
Min HY, Doyle LV, Vitt CR, et al.Urokinase receptor antago-nists inhibit angiogenesis and primary tumor growth in syngeneicmice[J].Cancer Res, 1996, 56(10):2428-2433
|
| [33] |
Matsui T, Shigeta T, Umeda M, et al.Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer[J].Oral Surg. Oral Med. Oral Pathol. Oral Radiol, 2015, 120(4):436-442
|
| [34] |
Shintani S, Li C, Ishikawa T, et al.Expression of vascular endothelial growth factor A,B,C,and D in oral squamous cell carcinoma[J].Oral Oncology, 2004, 40(1):13-20
|
| [35] |
Lin J, Lalani AS, Harding TC, et al.Inhibition of lymphogenous metastasis using adenoassociated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor[J].Cancer Res, 2005, 65(15):6901-6909
|
| [36] |
Tvorogov D.Anisimov A,?Zheng W,et alEffective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization[J].Cancer Cell, 2010, 18(6):630-640
|
| [37] |
Yang Y, Gao Z, Ma Y, et al.Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells[J].Oncotarget, 2016, 7(25):38025-38035
|
| [38] |
Pytowski B, Goldman J, Persaud K, et al.Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody[J].Natl Cancer Inst, 2015, 97(1):14-21
|
| [39] |
Michaelsen SR, Poulsen HS, Hamerlik P.VEGF-C as a putative therapeutic target in cancer[J].Oncotarget, 2019, 10(40):3988-3990
|
| [40] |
Kodera Y, Katanasaka Y, Kitamura Y, et al.Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3[J].Breast Cancer Res, 2011, 13:R66-
|
